New publication: Higher level of use of BLC improves bladder cancer patient outcomes

On June 25, 2025 Photocure reported the publication of the study "Use of photodynamic diagnosis (PDD) at primary TURB*: Potential influence on recurrence and progression rates in NMIBC in a registry-based study using a country cohort" in the Scandinavian Journal of Urology this week (Press release, PhotoCure, JUN 25, 2025, View Source;utm_medium=email_campaign&utm_campaign=newsletter [SID1234654115]). An abstract of this study was first presented at the NUF 2022 congress in Helsinki.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

This Danish population study assesses recurrence and progression impact of BLC using national registries in Denmark. It shows beneficial impact on recurrence and progression in patients treated at clinics who have a higher level of use of BLC in primary patients, further strengthening the importance of BLC in bladder cancer care.